These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2801838)

  • 1. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of c-ras-Ki oncogene in human ovarian tumours.
    Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML
    Int J Cancer; 1989 Mar; 43(3):428-30. PubMed ID: 2925274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas.
    Zhou DJ; Gonzalez-Cadavid N; Ahuja H; Battifora H; Moore GE; Cline MJ
    Cancer; 1988 Oct; 62(8):1573-6. PubMed ID: 3167770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
    Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
    Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.
    Yoshida K; Tsuda T; Matsumura T; Tsujino T; Hattori T; Ito H; Tahara E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 57(5):285-90. PubMed ID: 2570489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
    Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
    J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary.
    Filmus JE; Buick RN
    Cancer Res; 1985 Sep; 45(9):4468-72. PubMed ID: 4028028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
    Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene alterations in primary human colon tumors.
    Alexander RJ; Buxbaum JN; Raicht RF
    Gastroenterology; 1986 Dec; 91(6):1503-10. PubMed ID: 2876925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular oncogenes in human teratocarcinoma cell lines.
    Tesch H; Fürbass R; Casper J; Lyons J; Bartram CR; Schmoll HJ; Bronson DL
    Int J Androl; 1990 Oct; 13(5):377-88. PubMed ID: 2283183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of ras oncogenes in primary human cancers.
    Feinberg AP; Vogelstein B
    Biochem Biophys Res Commun; 1983 Feb; 111(1):47-54. PubMed ID: 6187346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Ki-ras oncogene in human prostatic adenocarcinoma.
    Peehl DM; Wehner N; Stamey TA
    Prostate; 1987; 10(4):281-9. PubMed ID: 3601807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW; Robinson RA; Burgart LJ
    Mod Pathol; 1992 Jul; 5(4):410-4. PubMed ID: 1495946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
    Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
    Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of Ki-ras amplification and p53 gene mutations in adenocarcinomas of the human esophagus.
    Galiana C; Lozano JC; Bancel B; Nakazawa H; Yamasaki H
    Mol Carcinog; 1995 Dec; 14(4):286-93. PubMed ID: 8519418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the c-myc proto-oncogene in soft tissue sarcomas.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    Oncology; 1994; 51(1):13-7. PubMed ID: 8265096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.